BioStock Investor Meeting, March 16
On March 16, we arranged the first virtual BioStock Investor Meeting of 2022. The event gave representatives from a number of life science companies active in a wide range of therapeutic areas the opportunity to present their business case to investors and potential partners.
Showcasing companies included
- AlzeCure presented by CEO Martin Jönsson
- Aptahem presented by CEO Mikael LindstamÂ
- Carbiotix presented by CEO Kristofer Cook
- Emplicure presented by CEO Torbjörn W. LarssonÂ
- Idogen presented by CEOÂ Anders Karlsson
- Miris presented by CEO Camilla Myhre Sandberg
- Phase Holographic Imaging presented by CEO Peter EgelbergÂ
- Pharmiva presented by deputy CEO Karoline Akerjordet Â
- Prolight Diagnostics presented by CEO Ulf Bladin
- Promore Pharma presented by CEO Jonas Ekblom
- QuiaPEG presented by CEOÂ Marcus Bosson
- Respiratorius presented by CEO Johan DrottÂ
- Sensidose presented by CEOÂ Jack Spira
- Targinta presented by CEO Per NorlénÂ
You can also read about BioStock’s other events during 2022 below.